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A permanent pacemaker was inserted in eight patients
with the long QT syndrome. All had recurrent syncope
or seizures, six had documented torsade de pointes and
four had aborted sudden death. Among the eight pa-
tients, permanent pacing was instituted in three who
were unsuccessfully treated with both a beta-adrenergic
blocking agent and left cardiothoracic sympathectomy,
and in two who proved refractory or intolerant to beta-
blockers. Another three patients had pacemaker im-
plantation and long-term beta-blocker therapy because
of spontaneousatrioventricular (AV)blockin one, aborted
sudden death in one and patient preference in one.
After pacing (70 to 85 beats/min), there was no sig-
nificant change in the mean corrected QT interval, but
the mean QT interval decreased significantly (534.4 ±
51.4 to 425.6 ± 18.9 ms, p < 0.0001). Over a mean
follow-up period of 35.1 ± 18.9 months, all patients are
Untreated asymptomatic patients with the hereditary long
QT syndrome have a mortality rate of71 % (1,2). Treatment
with beta-adrenergic blocking agents is still associated with
a 6% risk of sudden death (3), as is left cervical thoracic
sympathectomy, when used for patients resistant to beta-
blockade (4). In a previous report (5), we detailed our ex-
perience with a subset of patients with the long QT syn-
drome, most of whom proved resistant to left cervical tho-
racic sympathectomy and beta-blocker therapy. We found
that temporary cardiac pacing in patients with the long QT
syndrome resulted in a uniform decrease of the QT interval.
The rationale for use of permanent pacing in patients who
were unsuccessfully treated with both left cervical thoracic
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alive and currently free of syncope. One patient without
a history of stress-induced syncope had two syncopal
episodes (believed to be due to hyperventilation) while
under severe emotional stress, but has been symptom
free for the past 5 years. One patient with an atrial
demand (AAI) pacemaker developed dizziness due to
documented episodes of AV block, but remains asymp-
tomatic after conversion to atrial rate-responsive dual
chamber (DOD) pacing.
Either atrial or ventricular pacing combined with
beta-blocker therapy appears to be effective treatment
for a subset of patients with the long QT syndrome, by
either preventing episodes of torsade de pointes or al-
leviatingsymptomsdue to bradycardia from beta-blocker
therapy.
(J Am Coli CardioI1987;LO:600-7)
sympathectomy and beta-blocker therapy originated from
these temporary pacing studies.
The role of permanent cardiac pacing for patients with
the long QT syndrome has not been established. Sporadic
reports of permanent cardiac pacing for patients with the
idiopathic long QT syndrome almost always with associated
atrioventricular (AV) block or bradyarrhythmias, or both,
are available (6-8) and do not allow for definitive conclu-
sions relative to the long-term clinical effectiveness of this
approach. The purpose of this report is to detail our expe-
rience and evaluate the possible role of permanent pacing
for patients with this condition.
Methods
Study patients. The study is a retrospective analysis of
eight patients with the idiopathic long QT syndrome in whom
a permanent cardiac pacemaker was implanted as part of
their treatment between the years 1979 and 1985. During
this period, 20 patients were admitted to the University of
California, San Francisco, with the diagnosis of the long
QT syndrome. Ten patients responded to beta-blocker ther-
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apy alone, one to beta-blocker therapy and phenytoin (Di-
lantin), one to left cervical thoracic sympathectomy alone
and another to left cervical thoracic sympathectomy and
beta-blocker therapy. Six patients had permanent pacemaker
implantation (Cases I to 5 and 8) and are part of this report.
Two additional patients are among fi ve patients with the
long QT syndrome treated at the University of Southern
California and the University of Minnesota (Cases 6 and 7)
and are included in this report. Three of these patients were
treated with beta-blockers and two with a permanent pace-
maker. There was no significant difference in age, sex dis-
tribution or cardiac diagnosis between those treated with or
without a pacemaker. None of the paced patients experi-
enced syncope related to emotional upset, startle, fright or
exercise. In contrast, 3 of the 17 patients who were not
treated with a pacemaker had a history of adrenergic-me-
diated episodes of syncope.
Clinical characteristics (Table 1). There were eight
women, ranging in age from 16 to 57 years mean ± SO
32. 1 ± 11 .8). Congenital bilateral hearing loss was diag-
nosed in one patient (Case 4) . The long QT syndrome was
familial in fi ve patients (Cases 3 and 8 are relatives), and
sporadic in three patients.
All patients had recurrent syncopal episodes (abrupt loss
of consciousness) over a period of 5 to 49 years (mean ±
SO 15.2 ± 13.6), and four patients had one to four episodes
of aborted sudden death (requiring cardiopulmonary resus-
citation) before the insertion of a permanent pacemaker.
Two of the four had one episode of aborted sudden death,
while two had repeated episodes. Episodes of torsade de
pointes were recorded in six patients. Second degree atrio-
ventricular (AV) block (Mobitz type ll ) was documented in
two patients. All patients were free of associated cardiac
disease, except for Patient 2, who had mitral valve prolapse.
The eight patients had a prolonged QT interval at rest.
which was unrelated to drugs, electrolyte abnormalities,
myocardial ischemia or central nervous system disease. The
QT interval was measured from at least three 12 lead elec-
trocardiograms using the technique of Lepeschkin (9), and
the corrected QT interval (QTc) was determined by nor-
malizing the QT interval for heart rate (QTc = QT/YRR
( 10). A QTc 0.44 second or greater was considered abnor-
mal ( I I) .
Diagnostic testing. Maneuvers such as fright, startle,
Valsalva maneuver and exercise treadmill testing proved
ineffective in eliciting episodes of torsade de pointes. The
QT interval shortened with exercise in all patients. Invasive
electrophysiologic studies were performed in six of the eight
patients before the implantation of a permanent pacemaker
using a protocol previously reported ( 12).
Therapy. Four patients underwent left cervical thoracic
sympathectomy in which a thoracotomy was used to resect
the left stellate ganglion together with four to six thoracic
ganglia. The lack of effective response to surgery for three
patients (Cases 2 to 4) was previously reported (5) .
Indications fo r permanent pacemaker implantation in-
cluded failure to respond (or drug intolerance) to treatment
with left cervical thoracic sympathectomy or beta-blockers,
a history of aborted sudden death, a family history of sudden
death in symptomatic patients or occurrence of torsade de
pointes associated with bradyarrhythmias. Three different
types of permanent pacemakers were implanted: atrial de-
mand (AAI), atrial rate-responsive dual chamber (DOD) or
ventricular demand (VVI) pacemaker. The pacing rates were
guided by the magnitude of QT shortening achieved by atrial
or ventricular pacing, or both, over a physiologic range (70
to 90 beats/min) after full beta-blockade was achieved with
drug therapy. Maximal shortening of the QT interval within
this heart rate range served as the end point for choice of
the permanent paced ratc.
Table l. Cl inical Characterist ics o f the Eig ht Pat ient s
Duration of Torsade
Case Age (yr) Syncope ASD Symptoms de Current Follow-up
No. &Sex FH (no) (no) ( y r) Pointes Bradycardia Unsuccessful Therapy Therapy (mo)
33F 10 7 + Propranolol. XO LCTS 32
rng/day: phenytoin
2 32F 5 I.) + 5B(l3B) Nadolol, 120 rug/day: LCTS 35
phenytoin
3 16F + > 20 4 I.) + AVI.J Propranolol. 120 LCTS 43
rug/day: phenytoin
4 33F + > 20 21 + SB Propranolol, 120 LCTS 84
mg/day; phenytoin
5 27F 7 7 SB(BB) Nadolol. 120 rng/day 20
6 19F + > 10 2 5 + Phenobarbital 2S
7 24F + 8 15 + AVB, SB Phenytoin 43
H 57F + > 40 41.) Phenytoin 12
ASD = aborted sudden death: AVB = atrioventricular block (Mobitz type 1\): BB ~ after beta-blocker therapy: FH = family history of recurrent
syncope, or sudden death, or both: LCTS = left cervicothoracic sympathectomy: SB = sinus bradycardia.
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All patients were followed up by one of us or the referring
physician at intervals of 3 to 6 months.
Statistics. Values are expressed as mean values + stan-
dard deviation. The two-tailed Student's t test for paired
data was used to compare QT values before and after pace-
maker implantation in the same patients.
Results
The eight patients are divided into three groups, de-
pending on the indications for pacemaker insertion.
Group I. This group included three patients who under-
went cardiac pacing after failure of response to both beta-
blockers and left cervical thoracic sympathectomy. Patient
I had documented torsade de pointes after removal of the
left stellate ganglion. Repeated episodes of torsade de pointes,
which were not related to bradycardia, occurred in spite of
more extensive resection of the left thoracic chain (to T4)
and treatment with propranolol (800 mg/day). She has been
without symptoms for 2.5 years after treatment with a per-
manent cardiac pacemaker and beta-blocker therapy.
Patient 2 suffered from recurrent episodes of dizziness
and syncope, and was referred after an episode of aborted
sudden death. Episodes of polymorphous ventricular tachy-
cardia were not related to bradycardia (Fig. I). She under-
went left cervical thoracic sympathectomy and had recurrent
dizzy spells in spite of maximally tolerable doses of nadolol
(120 mg/day). The Holter electrocardiographic (ECG) re-
cordings showed chronic sinus bradycardia (42 to 53
beats/min), and episodes of dizziness were correlated with
bouts of polymorphous ventricular tachycardia that occurred
Figure I. Patient 2. Twelve lead electrocar-
diogram showing a heart rate of approximately
82 beats/min, a markedly prolonged QT in-
terval (0.60 second) and repolarization abnor-
malities. The rhythm strip shows a sinus rate
of 75 beats/min followed by an episode of tor-
sade de pointes. The heart rate remained within
normal limits throughout the hospital stay.
after pauses induced by ventricular ectopic beats (Fig. 2).
She underwent insertion of the AAI pacemaker and remains
asymptomatic over a follow-up period of 30 months.
Patient 3 had recurrent episodes of syncope and required
cardiac resuscitation on three occasions. Multiple episodes
of syncope due to torsade de pointes were documented and
were not associated with bradycardia (Fig. 3). At the age
of 7 years, she underwent left stellate ganglion resection at
another institution, but continued to have recurrent syncope
in spite of daily treatment with propranolol (120 mg/day)
and dilantin (300 mg/day). She was referred to our center
at 14 years of age after another episode of aborted sudden
death. She underwent left cervical thoracic sympathectomy
and an atrial pacemaker was inserted because of undue sinus
bradycardia associated with beta-blocker therapy. She had
no evidence of AV conduction disturbances. She remained
asymptomatic for 2 years and then had a recurrence of her
original symptoms (syncope) when pacemaker malfunction
due to fractured leads was found. She remains without
symptoms after appropriate pacing was instituted. Her fol-
low-up course is discussed in detail later in this report.
Group II. This group included two patients who proved
refractory or intolerant to beta-blocker therapy alone. Pa-
tient 4 had sinus node dysfunction and documented torsade
de pointes, both associated with as well as unrelated to sinus
bradycardia. Treatment with propranolol (120 mg/day) was
associated with increased episodes of syncope and one ep-
isode of aborted sudden death. She subsequently underwent
concomitant left cervical thoracic sympathectomy and AAI
pacemaker implantation. In Patient 5, maximally tolerated
doses of beta-blockers (nadolol, 120 mg/day) relieved her
of syncope, but produced fatigue owing to profound sinus
t! • .•• t •• , . •• • • •
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Figure 2. Patient 2. A, Nonsustained
episode of polymorphous ventricular
tachycardia recorded by Holter electro-
cardiographic monitoring after left
cervicothoracic sympathectomy during
treatment with a beta-blocking agent. This
patient developed chronic sinus brady-
cardia with beta-blocker therapy. and ep-
isodes of symptomatic polymorphous
ventricular tachycardia occurred after
pauses associated with ventricularectopic
complexes. B, Atrial pacing at a rate of
85 beats/min with absence of ventricular
ectopic activity.
bradycardia. She is currently without symptoms after pace-
maker insertion and continued beta-blocker therapy.
Group III. Three patients (Cases 6 to 8) were treated
with permanent pacing and beta-blocker therapy without a
trial of beta-blocking agents alone. All three had a history
of recurrent syncope. One patient (Case 8) declined beta-
blocker therapy alone because both her daughter (treated
with left cervical thoracic sympathectomy) and granddaugh-
Figure 3. Patient 3. Twelve lead electrocardio-
gram (ECG) showing sinus rhythm at rate of 72
beats/min and a prolonged QT interval (0.60 sec-
ond). Shortly after the 12 lead ECG was recorded.
a monitored rhythm strip shows an episode of
torsade de pointes. The sinus rate immediately
preceding the arrhythmia was not recorded.
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Figure 4. Patient 3. A, Rest electrocardiogram shows a markedly
prolonged QT interval (0.64 second) . During exercise. the patient
develops 2: I atrioventricular (AV) block; P waves (P) are denoted
by the arrows. B, Simultaneous recording of two surface leads
(aVF and VI) and right atrial (RA) and His bundle (HBE) elec-
trograms. Atrial stimulation (S) at a cycle length of 600 ms is
followed by atrial depolarization (a) with a 2:1 AV block distal
to the bundle of His (h) deflection . V = ventricular deflection.
ter (Case 3) were unsuccessfully managed with drug treat-
ment alone. Patient 7 had associated AV block and was
therefore, treated with both a pacemaker and beta-blockers.
Patient 6 had two episodes of aborted sudden death, a family
history of sudden death and documented episodes of torsade
de pointes. Various treatment options were presented, in-
cluding therapy with beta-blockers alone, beta-blockers and
cardiac pacing, left cervical thoracic sympathectomy or in-
sertion of an automatic internal defibrillator. After all the
possible benefits and complications for each treatment reg-
imen were explored, she chose a trial of beta-blockers and
permanent cardiac pacing.
Electrophysiologic studies. In none of the six patients
who underwent ventricular stimulation was sustained ven-
tricular tachycardia or fibrillation induced. Nonsustained
polymorphous ventricular tachycardia was induced in three
patients. Incremental atrial and ventricular pacing was per-
formed in five patients and was associated with progressive
shortening of the QT interval in all. Two patients had 2:I
AV block, which proved to be infra-Hisian in one (Case 3)
who underwent electrophysiologic studies (Fig. 4). The right
ventricular effective refractory period for this patient was
250 ms.
Chronic pacemaker therapy and the QT interval (Ta-
ble 2). Four patients had an atrial demand (AAJ) pacemaker,
two had an atrial rate-responsive dual chamber (DDD) pace-
maker and two had a ventricular demand (VVI) pacemaker
implanted. The pacing rates (or lower rate for DDD pace-
makers) were 70 to 85 beats/min (mean 79.2 ± 4.8).
The electrocardiogram in all eight patients with a per-
manent pacemaker showed shortening of the QT interval.
The QTc interval shortened in five patients, did not change
in one and lengthened in two. For the group as a whole,
permanent pacing resulted in a significant shortening of the
mean QT interval (from 534.4 ± 51.4 before to 425.5 ±
18.9 ms after pacing, p < 0.0001) . The QTc interval short-
ened (from 526.2 ± 35.6 to 483 ± 43.0 ms), but these
changes were not statistically significant. The degree of QT
shortening was similar among those treated with an AAI
(472.5 ± 13.0 to 405.0 ± 29.6 ms), DDD (560.0 ± 40.0
to 440.0 ± 0 ms) or VVI (555.0 ± 5 to 445 ± 35 ms)
pacemaker.
Follow-up (Table 1). The patients have been followed
up for 35.1 ± 18.9 months. All patients are alive and
currently without symptoms; none had recurrence of aborted
sudden death. Repeated continuous ECG recordings in these
patients showed, at most, ventricular couplets. Patient 3 had
an atrial pacemaker inserted at the time of her cervical
thoracic sympathectomy and was maintained on long-term
beta-blocker therapy. She remained without symptoms for
2 years when she had recurrent syncope and was found to
have a fractured pacemaker lead. The ECG showed sinus
rhythm without evidence of AV block. Her symptoms were
identical to those manifested before surgery and thought to
be related to recurrence of torsade de pointes (not docu-
mented). The lead was replaced by an endocardial unipolar
atrial lead and programmed in the AAI mode. Six months
before her last admission, she discontinued the beta-blocker
treatment and shortly afterward sustained two episodes of
dizziness documented to be due to episodic 2:I AV block
with a ventricular rate of 45 beats/min. In this patient. ces-
sation of beta-blocker therapy allowed for an increase in the
sinus rate, and rate-dependent infranodal block was docu-
mented (Fig. 4). A DDD pacemaker was implanted, and
the patient remains asymptomatic 5 months later.
Patient 4 underwent left cervical thoracic sympathec-
tomy. and an atrial demand pacemaker was inserted at a
rate of 70 beats/min. She had two syncopal episodes within
4 months after pacemaker insertion. These occurred when
she was under extreme stress related to divorce proceedings.
It was believed that these syncopal episodes were possibly
due to hyperventilation sinceher syncopal episodes (or aborted





Table 2. QT and QTc Intervals Before and After Implantation of a Permanent Pacemaker
Baseline Pacing
Case QT QTc Type of Rate QT QTc
No. (ms) (ms) Pacemaker (beats/min) (rns) (ms)
1 480 453 AAI X5 400 476
2 600 576 AAI X5 410 393
3 600 566 DDD XO 440 505
4 480 500 AAI 70 440 47/\
5 520 553 DDD XO 440 4X3
6 560 52X VVI 74 410 455
7 560 502 VVI SO 460 552
8 450 530 AAI SO 420 525
AAI = atrial demand pacemaker; DDD = rate-responsive dual chamber pacemaker; VVI = ventricular
demand pacemaker.
sudden death) before surgery were not related to emotional
upset or exercise. She has remained asymptomatic for the
next 75 months.
Discussion
This study describes eight patients with symptomatic
idiopathic long QT syndrome in whom a permanent pace-
maker was implanted as a part of treatment. The most im-
portant finding was the efficacy of permanent pacing and
beta-blockers therapy for three patients (Cases I. 2 and 3)
without bradycardia-mediated torsade de pointes who did
not respond to combined medical and surgical treatment.
This is of special importance in terms of the reported in-
cidence of sudden death for those who fail to respond to
available therapy. In addition, permanent pacing plays an
obvious role in alleviating bradycardia-related symptoms
induced by beta-blocking drugs. Our data showed that either
spontaneous or beta-blocker-induced bradycardia may act
as a provocative agent for episodes of torsade de pointes in
patients with the long QT syndrome (Cases 2, 4 and 7) and
that permanent pacing and beta-blocker therapy can control
these arrhythmias.
Mechanisms of torsade and rationale for pacing.
Several mechanisms have been invoked to explain the oc-
currence of torsade de pointes in patients with the long QT
syndrome. The most popular relates to asynchronous cardiac
sympathetic innervation and dispersion of ventricular re-
fractoriness (3,13,14). Critically timed premature ventric-
ular depolarizations in this milieu might initiate serious reen-
trant ventricular arrhythmias. An impressive array of data
suggests that these arrhythmias may be neurogenically (ad-
renergic) mediated. Permanent pacing may be efficacious
by decreasing the dispersion of refractoriness (14). In ad-
dition, if torsade de pointes is related to abnormal auto-
maticity of two or more ventricular foci (15), permanent
overdrive pacing may prove effective by decreasing auto-
maticity (16,17). A more recently proposed mechanism of
torsades de pointes relates to afterdepolarizations (18). It
has been shown that triggered rhythms relating to early
afterdepolarizations are enhanced by slow rates or factors
that prolong repolarization, or both (19). In Purkinje fibers,
cesium was found to induce bradycardia-dependent early
afterdepolarizations (20). It was recently shown that early
afterdepolarizations preceded the development of torsades
de pointes in dogs given anthropleurin-A (21). Whether
permanent cardiac pacing will abolish arrhythmias related
to early afterdepolarizations is, of course, conjectural.
In patients with the long QT syndrome, the episodes of
torsades de pointes are usually described as adrenergic de-
pendent (1,2,22-24) (and the majority of symptomatic pa-
tients respond to anti-adrenergic therapy). Unexplained by
this hypothesis is the finding of patients with the long QT
syndrome who fail to respond to beta-blocker therapy or left
cervical thoracic sympathectomy, or both. Described in this
report is a subset of patients with the long QT syndrome in
whom both symptoms and documented episodes of torsades
de pointes appear to be exacerbated by the occurrence of
bradyarrhythmias. The bradyarrhythmias occurred either
spontaneously or as a result of beta-blocker therapy. We
hypothesize that a subset of patients with the long QT syn-
drome may suffer from arrhythmia provocation by adre-
nergic-mediated mechanisms as well as by a decrease in
heart rate. It is of interest that permanent pacing and beta-
blocker therapy are the only therapeutic modalities that produce
consistent long-term normalization of the QT interval. Al-
though pacing alone would be expected to shorten the QT
interval, these effects are minimal in patients with a normal
heart rate if the desired pacing rate is to be maintained within
the normal range. The QT shortening with pacing is, how-
ever, accentuated by concomitant use of beta-blocking agents
that serve to slow the sinus rate.
AV block in the long QT syndrome. Two of our pa-
tients had Mobitz type II AV block. In one of the two who
underwent electrophysiologic studies, the site of block oc-
curred distal to the recorded His bundle potential. The oc-
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currence of AV block in patients with the long QT syndrome
had been previously described (8,25), but its prevalence is
not known. A recent study (26) has documented the co-
existence of infranodal lesions in these patients. The doc-
umentation of infra-Hisian AV block in combination with
relatively long ventricular repolarization (as 'judged by the
prolonged QT intervals) suggests that the block in these
patients might have been due to prolonged myocardial re-
fractoriness. However, the patient with AV block who
underwent electrophysiologic studies did not have abnormal
right ventricular effective refractory periods, suggesting that
the block occurred in the His-Putkinje system.
Type of implanted pacemaker. The long-term effec-
tiveness of permanent pacing was independent of the mode
of pacing (namely, atrial, ventricular or dual chamber).
Medina-Ravell et al. (6) found that DVI pacing shortened
the QT interval more than did ventricular pacing in one
patient with the long QT syndrome. In our patients, the QT
interval shortened to similar degrees with atrial and ven-
tricular pacing. Roy et al. (8) believed that an atrial rather
than a ventricular pacemaker should be implanted to avoid
induction of ventricular arrhythmias. In the early 1970s,
Olley and Fowler (24) described apparent aggravation of
arrhythmias by ventricular pacemaker wires. In contrast, no
arrhythmias were detected in four of our patients in whom
ventricular leads were implanted. This finding confirms sev-
eral recent reports (7,27). It is possible that more flexible
wires with more reliable ventricular fixation may account
for the difference.
Our results show that permanent ventricular pacing is not
contraindicated in patients with the long QT syndrome and
may, in fact, be desirable since some of these patients appear
to be prone to develop AV block. A dual chamber pace-
maker may be most appropriate for those requiring rate-
responsive pacing.
The pacing rates in our patients are generally slower than
those employed previously in patients with the long QT
syndrome (7,24). This is likely due to concomitant use of
a beta-blocking agent, which uniformly produced sinus
slowing in treated patients. The pacing rate in our series
was guided by achievement of "physiologic" rates that
produced clear-cut shortening of the QT interval.
Limitations of study. In three patients (Cases 6 to 8)
treated simultaneously with pacing and beta-blocking agents,
it is unclear whether treatment with a single modality would
have been effective. This group is nevertheless important
because it demonstrates efficacy of combined therapy in a
high risk group (syncope and aborted sudden death) and
suggests that combined therapy may be a suitable alternative
to more aggressive therapy (that is, sympathectomy or in-
sertion of an automatic defibrillator).
Clinical implications. Our observations have several
important practical implications. For patients with the long
QT syndrome presenting with transient neurologic symp-
toms that are adrenergic ally mediated, a trial of beta-blocker
therapy is indicated. On the basis of our observations, it
would appear reasonable to use permanent cardiac pacing
and beta-blocker therapy for those who do not respond to
beta-blocker therapy and left cervical thoracic sympathec-
tomy. In those patients in whom the mechanism of torsade
de pointes appears to be both adrenergic- and bradycardia-
dependent, treatment with permanent pacing and beta-blocker
therapy might prove to be a suitable alternative to left cer-
vical thoracic sympathectomy. Patients with the long QT
syndrome who present with aborted sudden death are a
particularly difficult group to treat. The incidence of sudden
death even after left cervical thoracic sympathectomy is still
6% and some have suggested use of the automatic internal
defibrillator for these patients. Our data raise the possibility
that a less aggressive approach including long-term beta-
blocker therapy and cardiac pacing might prove equally
effective.
References
I. Schwartz PJ. Idiopathic long QT syndrome: progress and questions.
Am Heart J 1985;109:399-411.
2. Moss AJ. Schwartz PJ. Crampton RS. Cocati E, Carleen E. The long
QT syndrome: a prospective international study. Circulation 1985;71:
17-21.
3. Schwartz PJ, Periti M. Malliani A. The long Q-T syndrome. Am
Heart J 1975;89:378-90.
4. Schwartz PJ. The long QT syndrome. In: Kulbertus HE, Wellens HJJ,
eds. Sudden Death. The Hague: Martinus Nijhoff, 1980:358-78.
5. Bhandari AK, Scheinman MM. Morady F. Svinarich J, Mason 1.
Winkle R. Efficacy of left cardiac sympathectomy in the treatment of
patients with the long QT syndrome. Circulation 1984;70:1018-23.
6. Medina-Ravell V, Castellanos A, Portillo-Acosta B, et al. Manage-
ment of tachyarrhythmias with dual-chamber pacemakers. PACE 1983;6:
333-45.
7. Di Segni E, David D, Katzenstein M, Klein HO, Kaplinsky E, Levy
MJ. Permanent overdrive pacing for the suppression of recurrent ven-
tricular tachycardia in a newborn with long QT syndrome. J Electro-
cardiol 1980;13:189-92.
8. Roy PR, Emanuel R, Ismail SA, EI Tayib MH. Hereditary prolon-
gation of the Q-T interval: genetic observations and management in
three families with twelve affected members. Am J Cardiol 1976;37:
23'7-43.
9. Lepeschkin E. Modem Electrocardiography. Vol. I. Baltimore: Wil-
liams & Wilkins, 1951:53.
10. Bazett He. An analysis of the time-relations of electrocardiograms.
Heart 1920;7:353-70.
II. Surawicz B, Knoebel SB. Long QT: good, bad or indifferent? J Am
Coll Cardio1 1984;4:398-413.
\2. Bhandari AK, Shapiro WA, Morady F, Shen E:.N, Mason J, Schein man
MM. Electrophysiologic testing in patients with the long QT syn-
drome. Circulation 1985;71:63-71.
13. Han J, Moe GK. Nonuniform recovery of excitability in ventricular
muscle. Circ Res 1964;14:44-60.
14. Han J, Millet D, Chizzonitti B, Moe GK. Temporal dispersion of
recovery of excitability in atrium and ventricle as a function of heart
rate. Am Heart J 1966;71:481-7.
15. Dessertenne F. La tachycardie ventriculaire a deux foyers opposes
variables. Arch Mal Coeur 1966;59:263-72.





16. Vassalle M. Electrogenic suppression of automaticity in sheep and
dog Purkinje fibers. Circ Res 1970;27:361-77.
17. Singer DH, Lazzara R,.Hoffman BF. Interrelationships between au-
tomaticity and conduction in Purkinje fibers. Circ Res 1967;21:537-58.
18. Schechter E, Freeman CC, Lazzara R. Afterdepolarizations as a mech-
anism for the long QT syndrome: electrophysiologic studies of a case.
J Am Coli Cardiol 1984;3: 1556-61.
19. Hoffman BF, Rosen MR. Cellular mechanisms for cardiac arrhyth-
mias. Circ Res 1981;49:1-15.
20. Damiano BP, Rosen MR. The effects of pacing on early afterdepo-
larizations and triggered activity (abstr). Fed Proc Fed Am Soc Exp
Bioi 1983;42:581.
21. Craelius W, Chen V, Zeiler R, EI-Sherif N. In vivo recording of early
afterdepolarizations preceding torsades de pointes (abstr). J Am Coli
CardioI1986;7:124A.
22. Jackman WM, Clark M, Friday KJ, Aliot EM, Anderson J, Lazzara
R. Ventricular tachyarrhythmias in the long QT syndromes. Med Clin
NA 1984;68:1079-109.
23. Ratshin RA, Hunt D, Russell RO, Rackley CEo QT-interval prolon-
gation, paroxysmal ventricular arrhythmias, and convulsive syncope.
Ann Intern Med 1971;75:919-24.
24. Olley PM, Fowler RS. The surdo-cardiac syndrome and therapeutic
observations. Br Heart J 1970;32:467-71.
25. Sharma S, Nair KG, Gadekar HA. Romano-Ward prolonged QT syn-
drome with intermittent T wave alternans and atrioventricular block.
Am Heart J 1981;101:500-1.
26. Bharati S, Dreifus L, Bucheleres G, et al. The conduction system in
patients with a prolonged QT interval. J Am Coli Cardiol 1985;6:
1110-9.
27. Crawford MH, Karliner JS, O'Rourke RA, Friedman WF. Prolonged
Q-T interval syndrome: successful treatment with combined ventric-
ular pacing and propranolol. Chest 1975;68:369-71.
